ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IS SUPERIOR TO IMMUNOSUPPRESSIVE THERAPY IN INDIAN CHILDREN WITH APLASTIC ANEMIA—A SINGLE-CENTER ANALYSIS OF 100 PATIENTS

REFERENCES

• Davies JK, Guinan EC. An update on the management of severe idiopathic aplastic anaemia in children. Br J Haematol. 2007;136:549–564.
   PubMed Web of Science ®Google Scholar
• Kennedy-Nasser AA, Leung KS, Mahajan A, Comparable outcomes of matched-related and alternative donor stem cell transplantation for pediatric severe aplastic anemia. Biol Blood Marrow Transplant. 2006; 12: 1277–1284.
   PubMed Web of Science ®Google Scholar
• Munoz Villa A, Ortega Aramburu JJ, Bureo Dacal E, Allogeneic bone marrow transplantation in children with severe acquired aplastic anemia. The long-term results. The Spanish Group for Bone Marrow Transplantation in Children (GETMON). An Esp Pediatr. 1999; 50:29–32.
   Google Scholar
• Locasciulli A, Oneto R, Bacigalupo A, et al; Severe Aplastic Anemia Working Party of the European Blood and Marrow Transplant Group. Outcome of patients with acquired aplastic anemia given first line bone marrow transplantation or immunosuppressive treatment in the last decade: a report from the European Group for Blood and Marrow Transplantation (EBMT). Haematologica. 2007;92:11–18.
   PubMed Web of Science ®Google Scholar
• Azuma E, Kojima S, Kato K, Conditioning with cyclophosphamide/antithymocyte globulin for allogeneic bone marrow transplantation from HLA-matched siblings in children with severe aplastic anemia. Bone Marrow Transplant. 1997; 19: 1085–1087.
   PubMedGoogle Scholar
• Kahl C, Leisenring W, Deeg HJ, Cyclophosphamide and antithymocyte globulin as a conditioning regimen for allogeneic marrow transplantation in patients with aplastic anaemia: a long term follow-up. Br J Haematol. 2005; 130: 747–751.
   PubMed Web of Science ®Google Scholar
• Kobayashi R, Yabe H, Hara J, Preceding immunosuppressive therapy with antithymocyte globulin and cyclosporin increases the incidence of graft rejection in children with aplastic anaemia who underwent allogeneic bone marrow transplantation from HLA-identical siblings. Br J Haematol. 2006;135:693–696.
   PubMed Web of Science ®Google Scholar
• Fuhrer M, Rampf U, Baumann I, Immunosuppressive therapy for aplastic anemia in children: a more severe disease predicts better survival. Blood. 2005;106:2102–2104.
   PubMed Web of Science ®Google Scholar
• Kojima S, Horibe K, Inaba J, Long-term outcome of acquired aplastic anaemia in children: comparison between immunosuppressive therapy and bone marrow transplantation. Br J Haematol. 2000;111:321–328.
   PubMed Web of Science ®Google Scholar
• Feng YH, Yen CJ, Huang WT, Clinical response of antilymphocyte globulin-based treatment in patients in Taiwan with aplastic anemia: positive hepatitis C antibody may represent a response predictor. Int J Hematol. 2004;79:133–137.
   PubMedGoogle Scholar
• Kojima S, Hibi S, Kosaka Y, Immunosuppressive therapy using antithymocyte globulin, cyclosporine, and danazol with or without human granulocyte colony-stimulating factor in children with acquired aplastic anemia. Blood. 2000;96:2049–2054.
   PubMed Web of Science ®Google Scholar
• de-Medeiros CR, Ribeiro RC, Bittencourt MA, Long-term outcome of 25 children and adolescents with severe aplastic anemia treated with antithymocyte globulin. Braz J Med Biol Res. 2000; 33:553–558.
   PubMedGoogle Scholar
• Matloub YH, Smith C, Bostrom B, One course versus two courses of antithymocyte globulin for the treatment of severe aplastic anemia in children. J Pediatr Hematol Oncol. 1997;19:110–114.
   Google Scholar
• Rosenfeld SJ, Kimball J, Vining D, Young NS. Intensive immunosuppression with antithymocyte globulin and cyclosporine as treatment for severe acquired aplastic anemia. Blood. 1995;85:3058– 3065.
   PubMed Web of Science ®Google Scholar
• Camitta BM. What is the definition of cure for aplastic anemia? Acta Haematol. 2000;103:16–18.
   PubMed Web of Science ®Google Scholar
• George B, Mathews V, Viswabandya A, Fludarabine based reduced intensity conditioning regimens in children undergoing allogeneic stem cell transplantation for severe aplastic anemia. Pediatr Transplant. 2008;12:14–19.
   PubMedGoogle Scholar
• Slavin S, Nagler A, Naparstek E, Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases. Blood. 1998;91:756–763.
   PubMed Web of Science ®Google Scholar
• Schrezenmeier H, Passweg JR, Marsh JC, Worse outcome and more chronic GVHD with peripheral blood progenitor cells than bone marrow in HLA-matched sibling donor transplants for young patients with severe acquired aplastic anemia. Blood. 2007;110:1397–1400.
   PubMed Web of Science ®Google Scholar
• Lo Ten Foe JR, Kwee ML, Rooimans MA, Somatic mosaicism in Fanconi anemia: molecular basis and significance. Eur J Hum Genet. 1997;5:137–148.
   PubMedGoogle Scholar
• Federman N, Sakamoto KM. The genetic basis of bone marrow failure syndromes in children. Mol Genet Metab. 2005;86:100–109.
   PubMed Web of Science ®Google Scholar
• Calado RT, Graf SA, Wilkerson KL, Mutations in the SBDS gene in acquired aplastic anemia. Blood. 2007;110:1141–1146.
   PubMedGoogle Scholar
• Yamaguchi H, Calado RT, Ly H, Mutations in TERT, the gene for telomerase reverse transcriptase, in aplastic anemia. N Engl J Med. 2005;352:1413–1424.
   PubMed Web of Science ®Google Scholar
• Ortmann CA, Niemeyer CM, Wawer A, TERC mutations in children with refractory cytopenia. Haematologica. 2006;91:707–708.
   PubMedGoogle Scholar
• Solomou EE, Gibellini F, Stewart B, Perforin gene mutations in patients with acquired aplastic anemia. Blood. 2007;109:5234–5237.
   PubMed Web of Science ®Google Scholar
• Gillio AP, Boulad F, Small TN, Comparison of long-term outcome of children with severe aplastic anemia treated with immunosuppression versus bone marrow transplantation. Biol Blood Marrow Transplant. 1997;3:18–24.
   PubMedGoogle Scholar
• Bacigalupo A, Locatelli F, Lanino E, et al; Severe Aplastic Anemia Working Party of the European Group for Blood and Marrow Transplantation. Fludarabine, cyclophosphamide and anti-thymocyte globulin for alternative donor transplants in acquired severe aplastic anemia: a report from the EBMT-SAA Working Party. Bone Marrow Transplant. 2005;36:947–950.
   PubMed Web of Science ®Google Scholar
• Passweg JR, Perez WS, Eapen M, Bone marrow transplants from mismatched related and unrelated donors for severe aplastic anemia. Bone Marrow Transplant. 2006;37:641–649.
   PubMed Web of Science ®Google Scholar
• Gluckman E, Rocha V, Chastang C. European results of unrelated cord blood transplants. Eurocord group. Bone Marrow Transplant. 1998;21(Suppl 3):S87-S91.
   Google Scholar
• Tzeng CH, Chen PM, Fan S, CY/TBI-800 as a pretransplant regimen for allogeneic bone marrow transplantation for severe aplastic anemia using HLA-haploidentical family donors. Bone Marrow Transplant. 1996;18:273–277.
   PubMed Web of Science ®Google Scholar